Application of aptamers in therapeutics and for small-molecule detection

Handbook of Experimental Pharmacology

Volumn 173, Issue , 2006, Pages 359-373

  Menger, M ^a   Glokler J ^a   Rimmele, M ^a  

^a RiNA Netzwerk RNA Technologien   (Germany)

Author keywords

Aptamers; Biosensor; Detection; Low molecular weight compounds; Small molecules

Indexed keywords

EID: 85099485951     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-27262-3_18     Document Type: Article

References (90)

1. Ahmed N, Thornalley PJ (2003) Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 31:1417-1422
2. AltriaKD, ElderD(2004)Overview of the status and applications of capillary electrophoresis to the analysis of small molecules. J Chromatogr A 1023:1-14
3. Aurup H, Williams DM, Eckstein F (1992) 2′-Fluoro- and 2′-amino-2′-deoxynucleoside 5′-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31:9636-9641
4. Baldrich E,Restrepo A,O'SullivanCK(2004)Aptasensor development: elucidation of critical parameters for optimal aptamer performance. Anal Chem 76:7053-7063
5. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564-566
6. Breaker RR (2002) Engineered allosteric ribozymes as biosensor components. Curr Opin Biotechnol 13:31-39
7. Breaker RR (2004) Natural and engineered nucleic acids as tools to explore biology. Nature 432:838-845
8. Brody EN, Gold L (2000) Aptamers as therapeutic and diagnostic agents. J Biotechnol 74:5-13
9. Bruno JG, Kiel JL (2002) Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymaticmethods. Biotechniques 32:178- 80, 182-183
10. Burgstaller P, Jenne A, BlindM(2002)Aptamers and aptazymes: accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 5:690-700
11. Chelliserrykattil J, Ellington AD (2004) Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA. Nat Biotechnol 22:1155-1160
12. Cicortas Gunnarsson L, Nordberg Karlsson E, Albrekt AS, Andersson M, Holst O, Ohlin M (2004) A carbohydrate binding module as a diversity-carrying scaffold. Protein Eng Des Sel 17:213-221
13. Clark SL, Remcho VT (2003) Electrochromatographic retention studies on a flavin-binding RNA aptamer sorbent. Anal Chem 75:5692-5696
14. Clegg RM (1995) Fluorescence resonance energy transfer. Curr Opin Biotechnol 6:103-110
15. Cox JC, Ellington AD (2001) Automated selection of anti-protein aptamers. Bioorg Med Chem 9:2525-2531
16. Cox JC, Hayhurst A, Hesselberth J, Bayer TS, Georgiou G, Ellington AD (2002) Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res 30:e108
17. Daniels DA, Sohal AK, Rees S, Grisshammer R (2002) Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. Anal Biochem 305:214-226
18. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822
19. Eulberg D, Klussmann S (2003) Spiegelmers: biostable aptamers. Chembiochem 4:979-983
20. Eyetech Study Group (2002) Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 22:143-152
21. Famulok M (1999) Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol 9:324-329
22. Famulok M,Mayer G (1999) Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol 243:123-136
23. Famulok M, Verma S (2002) In vivo-applied functional RNAs as tools in proteomics and genomics research. Trends Biotechnol 20:462-466
24. Famulok M, Blind M, Mayer G (2001) Intramers as promising new tools in functional proteomics. Chem Biol 8:931-939
25. Fedor MJ (2002) The role of metal ions in RNA catalysis. Curr Opin Struct Biol 12:289-295
26. Glokler J, Angenendt P (2003) Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797:229-240
27. Gold L, Polisky B, Uhlenbeck O, Yarus M (1995) Diversity of oligonucleotide functions. Annu Rev Biochem 64:763-797
28. Good PD, Krikos AJ, Li SX, Bertrand E, Lee NS, Giver L, Ellington A, Zaia JA, Rossi JJ, Engelke DR (1997) Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 4:45-54
29. Grate D,Wilson C (2001) Inducible regulation of the S. cerevisiae cell cycle mediated by an RNA aptamer-ligand complex. Bioorg Med Chem 9:2565-2570
30. Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Leung LL (1993) In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 81:3271-3276
31. Hanna R, Doudna JA (2000)Metal ions in ribozyme folding and catalysis. Curr Opin Chem Biol 4:166-170
32. HentzeMW,Kuhn LC (1996)Molecular control of vertebrate iron metabolism:mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175-8182
33. Hermann T, PatelDJ (2000)Adaptive recognition by nucleic acid aptamers. Science 287:820-825
34. Hewitt CJ, Nebe-Von-Caron G (2004) The application of multi-parameter flow cytometry to monitor individual microbial cell physiological state. Adv Biochem Eng Biotechnol 89:197-223
35. Homann M, Goringer HU (2001) Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic "piggy-back" approach. Bioorg Med Chem 9:2571-2580
36. InabaY,Hamada-Sato N,Kobayashi T, Imada C,Watanabe E (2003) Determination of D- and L-alanine concentrations using a pyruvic acid sensor. Biosens Bioelectron 18:963-971
37. IyoM, KawasakiH, Taira K (2002) Allosterically controllable maxizymes for molecular gene therapy. Curr Opin Mol Ther 4:154-165
38. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628-1650
39. Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, Kirschenheuter G, McGee DP, Abesinghe P, Pieken WA, et al (1995) Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363-11372
40. Kawakami J, Imanaka H, Yokota Y, Sugimoto N (2000) In vitro selection of aptamers that act with Zn2+. J Inorg Biochem 82:197-206
41. Kim SJ, Kim MY, Lee JH, You JC, Jeong S (2002) Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein. Biochem Biophys Res Commun 291:925-931
42. Klussmann S, Nolte A, Bald R, Erdmann VA, Furste JP (1996) Mirror-image RNA that binds D-adenosine. Nat Biotechnol 14:1112-1115
43. Koizumi M, Breaker RR (2000) Molecular recognition of cAMP by an RNA aptamer. Biochemistry 39:8983-8992
44. Kubodera T, Watanabe M, Yoshiuchi K, Yamashita N, Nishimura A, Nakai S, Gomi K, Hanamoto H (2003) Thiamine-regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5′-UTR. FEBS Lett 555:516-520
45. Lorsch JR, Szostak JW (1994) In vitro selection of RNA aptamers specific for cyanocobalamin. Biochemistry 33:973-982
46. Lottspeich F, ZorbosH(1998) Bioanalytik. Spektrum Akad. Verlag,Heidelberg, Berlin, New York, pp 9-463
47. Lutz R, Bujard H (1997) Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res 25:1203-1210
48. Meis JE, Chen F (2002) In vitro synthesis of 2′-fluoro-modified RNA transcripts that are completely resistant to RNase A digestion using the DuraScribe TMT7 transcription kit. Epicentre Forum 9:10-11
49. Menger M, Tuschl T, Eckstein F, Porschke D (1996) Mg(2+)-dependent conformational changes in the hammerhead ribozyme. Biochemistry 35:14710-14716
50. Nicholls H (2003) Improving drug response with pharmacogenomics. Drug Discov Today 8:281-282
51. Nimjee SM, Rusconi CP, Sullenger BA (2005) APTAMERS: An Emerging Class of Therapeutics. Annu Rev Med 56:555-583
52. Nix J, SussmanD,WilsonC(2000) The 1.3Acrystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition. J Mol Biol 296:1235-1244
53. Nonin-Lecomte S, Lin CH, PatelDJ (2001)Additional hydrogen bonds and base-pair kinetics in the symmetrical AMP-DNA aptamer complex. Biophys J 81:3422-3431
54. O'Sullivan CK (2001) Aptasensors-the future of biosensing? Anal Bioanal Chem 372:44-48
55. Ooms M, Huthoff H, Russell R, Liang C, Berkhout B (2004) A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol 78:10814-10819
56. Patel DJ (1997) Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1:32-46
57. Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F (1991) Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253:314-317
58. Rajendran M, Ellington AD (2002) Selecting nucleic acids for biosensor applications. Comb Chem High Throughput Screen 5:263-270
59. Rimmele M (2003) Nucleic acid aptamers as tools and drugs: recent developments. Chembiochem 4:963-971
60. Rimmele M, Ehrentreich-Forster E (2004)Nukleinsauren als biochemische Fangermolekule. BIOforum 04:68-69
61. Roychowdhury-Saha M, Lato SM, Shank ED, BurkeDH(2002) Flavin recognition by an RNA aptamer targeted toward FAD. Biochemistry 41:2492-2499
62. Rubin B, Sonderstrup G (2004) Citrullination of self-proteins and autoimmunity. Scand J Immunol 60:112-120
63. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273:20556-20567
64. Rusconi CP, Scardino E, Layzer J, Pitoc GA, Ortel TL, Monroe D, Sullenger BA (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419:90-94
65. Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G Jr, Scardino E, Fay WP, Sullenger BA (2004) Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 22:1423-1428
66. Sousa R, Padilla R (1995) A mutant T7 RNA polymerase as a DNA polymerase. EMBO J 14:4609-4621
67. Sudarsan N, Barrick JE, Breaker RR (2003)Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 9:644-647
68. Suess B, Fink B, Berens C, Stentz R, Hillen W (2004) A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res 32:1610-1614
69. Sun S (2000) Technology evaluation: SELEX, Gilead Sciences Inc. Curr Opin Mol Ther 2:100-105
70. SussmanD, GreensidesD, Reilly K,Wilson C (1999) Preliminary characterization of crystals of an in vitro evolved cyanocobalamin (vitamin B12) binding RNA. Acta Crystallogr D Biol Crystallogr 55:326-328
71. Szabo A, Stolz L, Granzow R (1995) Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). Curr Opin Struct Biol 5:699-705
72. Toulme JJ, Di Primo C, Boucard D (2004) Regulating eukaryotic gene expression with aptamers. FEBS Lett 567:55-62
73. Tucker CE, Chen LS, JudkinsMB, Farmer JA,Gill SC, DroletDW(1999) Detection and plasma pharmacokineticsofananti-vascularendothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. J Chromatogr B Biomed Sci Appl 732:203-212
74. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510
75. Ulrich H, Magdesian MH, Alves MJ, ColliW(2002) In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 277:20756-20762
76. Vinores SA (2003) Technology evaluation: pegaptanib, Eyetech/Pfizer. Curr Opin Mol Ther 5:673-679
77. Vogt M, Skerra A (2004) Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. Chembiochem 5:191-199
78. Vuyisich M, Beal PA (2002) Controlling protein activity with ligand-regulated RNA aptamers. Chem Biol 9:907-913
79. Walter G, Bussow K, Lueking A, Glokler J (2002) High-throughput protein arrays: prospects for molecular diagnostics. Trends Mol Med 8:250-253
80. Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, Fan M, Shen B, Shao N (2003) Single-strandedDNAaptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102:15-22
81. White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B (2001) Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther 4:567-573
82. White RR, Sullenger BA, Rusconi CP (2000) Developing aptamers into therapeutics. J Clin Invest 106:929-934
83. Wibrand F (2004) A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum. Clin Chim Acta 347:89-96
84. Wilson C, Nix J, Szostak J (1998) Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot. Biochemistry 37:14410-14419
85. Wilson DS, Szostak JW (1999) In vitro selection of functional nucleic acids. Annu Rev Biochem 68:611-647
86. WinklerWC, Cohen-Chalamish S, Breaker RR (2002) AnmRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci USA 99:15908-15913
87. Woodbury CP Jr, Venton DL (1999) Methods of screening combinatorial libraries using immobilized or restrained receptors. J Chromatogr B Biomed Sci Appl 725:113-137
88. Zaydan R, Dion M, BoujtitaM(2004) Development of a new method, based on a bioreactor coupledwith an L-lactate biosensor, toward the determination of a nonspecific inhibition of L-lactic acid production during milk fermentation. J Agric Food Chem 52:8-14
89. Zhang Z, Blank M, Schluesener HJ (2004) Nucleic acid aptamers in human viral disease. Arch Immunol Ther Exp (Warsz) 52:307-315
90. Zhu H, Snyder M (2003) Protein chip technology. Curr Opin Chem Biol 7:55-63